AU Patent

AU2011250768A1 — Pharmaceutical forms with improved pharmacokinetic properties

Assigned to Bayer Intellectual Property GmbH · Expires 2011-12-08 · 14y expired

What this patent protects

PHARMACEUTICAL FORMS WITH IMPROVED PHARMACOKINETIC Abstract The invention relates to novel pharmaceutical formulations of Vardenafil, which rapidly 5 dissolve in the mouth and lead to an increase in bioavailability and a plateau-shaped plasma concentration curve and method for pr…

USPTO Abstract

PHARMACEUTICAL FORMS WITH IMPROVED PHARMACOKINETIC Abstract The invention relates to novel pharmaceutical formulations of Vardenafil, which rapidly 5 dissolve in the mouth and lead to an increase in bioavailability and a plateau-shaped plasma concentration curve and method for production thereof.

Drugs covered by this patent

vardenafil-hydrochloride (VARDENAFIL HYDROCHLORIDE)

Patent Metadata

Patent number: AU2011250768A1
Jurisdiction: AU
Classification: —
Expires: 2011-12-08
Drug substance claim: No
Drug product claim: No
Assignee: Bayer Intellectual Property GmbH
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.